• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 1999-2010 年宫颈癌、子宫内膜癌和卵巢癌的发病率。

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.

机构信息

Center for Uterine Cancer, National Cancer Center, Goyang, Korea.

出版信息

J Gynecol Oncol. 2013 Oct;24(4):298-302. doi: 10.3802/jgo.2013.24.4.298. Epub 2013 Oct 2.

DOI:10.3802/jgo.2013.24.4.298
PMID:24167664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3805909/
Abstract

OBJECTIVE

To investigate the recent incidence of and trends in cervical, endometrial, and ovarian cancer in Korean females.

METHODS

Data from the Korea Central Cancer Registry between 1999 and 2010 were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) were calculated.

RESULTS

THE ABSOLUTE INCIDENCE RATES OF THE THREE MAJOR GYNECOLOGIC CANCERS INCREASED: 6,394 in 1999 to 7,454 in 2010. The ASR for gynecologic cancer was 23.7 per 100,000 in 1999 and decreased to 21.0 in 2010 (APC, -1.1%; 95% confidence interval [CI], -1.53 to -0.70) due to a definitive decrease in the incidence of cervical cancer (APC, -4.3%). Endometrial cancer has been definitively increasing (APC, 6.9% during 1999-2010), especially in females <30 years old (APC, 11.2%) and in females ≥80 years old (APC, 9.5%). The incidence of ovarian cancer is increasing gradually (APC, 1.5%).

CONCLUSION

ASRs and APC for gynecologic cancers overall are decreasing due to the decrease in the incidence of cervical cancer. However, the incidence of endometrial and ovarian cancer has been increasing.

摘要

目的

调查韩国女性宫颈癌、子宫内膜癌和卵巢癌的近期发病率和趋势。

方法

对 1999 年至 2010 年韩国中央癌症登记处的数据进行分析。计算年龄标准化率(ASR)和年百分变化(APC)。

结果

三种主要妇科癌症的绝对发病率均呈上升趋势:1999 年为 6394 例,2010 年增至 7454 例。1999 年妇科癌症的 ASR 为每 10 万人 23.7,2010 年降至 21.0(APC,-1.1%;95%置信区间[CI],-1.53 至-0.70),这主要归因于宫颈癌发病率的明确下降(APC,-4.3%)。子宫内膜癌的发病率一直在明确增加(APC,1999-2010 年期间为 6.9%),尤其是 30 岁以下女性(APC,11.2%)和 80 岁以上女性(APC,9.5%)。卵巢癌的发病率也在逐渐上升(APC,1.5%)。

结论

由于宫颈癌发病率的下降,妇科癌症的 ASR 和 APC 总体呈下降趋势。然而,子宫内膜癌和卵巢癌的发病率一直在上升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61cb/3805909/b75626cb40a2/jgo-24-298-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61cb/3805909/829b472cbff6/jgo-24-298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61cb/3805909/b75626cb40a2/jgo-24-298-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61cb/3805909/829b472cbff6/jgo-24-298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61cb/3805909/b75626cb40a2/jgo-24-298-g002.jpg

相似文献

1
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.韩国 1999-2010 年宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2013 Oct;24(4):298-302. doi: 10.3802/jgo.2013.24.4.298. Epub 2013 Oct 2.
2
Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.1999-2015 年韩国宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2019 Jan;30(1):e38. doi: 10.3802/jgo.2019.30.e38.
3
Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.1993-2013 年以色列妇科恶性肿瘤与种族相关的趋势。
Int J Gynaecol Obstet. 2018 Aug;142(2):176-181. doi: 10.1002/ijgo.12524. Epub 2018 May 30.
4
The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry.1999 - 2017年韩国宫颈癌、卵巢癌和子宫内膜癌的发病率及生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2021 Sep;64(5):444-453. doi: 10.5468/ogs.21116. Epub 2021 Aug 17.
5
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.1999年至2012年韩国上皮性卵巢癌按组织学亚型划分的发病率
J Gynecol Oncol. 2016 Jan;27(1):e5. doi: 10.3802/jgo.2016.27.e5. Epub 2015 Dec 1.
6
Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.塞尔维亚中部女性人群中最常见妇科癌症发病率的时间变化。
Medicina (Kaunas). 2022 Feb 17;58(2):306. doi: 10.3390/medicina58020306.
7
Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.韩国 1993 年至 2009 年按年龄组和组织学类型划分的原位和浸润性宫颈癌发病率趋势。
PLoS One. 2013 Aug 16;8(8):e72012. doi: 10.1371/journal.pone.0072012. eCollection 2013.
8
Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.1999 - 2019年韩国妇科癌症(包括宫颈癌、子宫癌、卵巢癌、阴道癌、外阴癌和妊娠滋养细胞肿瘤)的发病率和生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2023 Nov;66(6):545-561. doi: 10.5468/ogs.23208. Epub 2023 Oct 27.
9
Trends in major cancer mortality in Korea, 1983-2012, with a joinpoint analysis.1983 - 2012年韩国主要癌症死亡率趋势及连接点分析
Cancer Epidemiol. 2015 Dec;39(6):939-46. doi: 10.1016/j.canep.2015.10.023. Epub 2015 Nov 9.
10
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.1999-2018 年韩国国家癌症登记处宫颈癌的发病率和治疗结果。
J Gynecol Oncol. 2023 Mar;34(2):e39. doi: 10.3802/jgo.2023.34.e39. Epub 2023 Jan 19.

引用本文的文献

1
The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer.BRCA突变位置与PARP抑制剂作为晚期上皮性卵巢癌一线维持治疗疗效之间的关联
Cancers (Basel). 2025 Feb 23;17(5):756. doi: 10.3390/cancers17050756.
2
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.PARP 抑制剂维持治疗对新诊断的晚期上皮性卵巢癌的影响:一项荟萃分析。
PLoS One. 2023 Nov 17;18(11):e0294647. doi: 10.1371/journal.pone.0294647. eCollection 2023.
3
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.

本文引用的文献

1
Prediction of cancer incidence and mortality in Korea, 2013.2013 年韩国癌症发病率与死亡率预测。
Cancer Res Treat. 2013 Mar;45(1):15-21. doi: 10.4143/crt.2013.45.1.15. Epub 2013 Mar 31.
2
Increasing trend of colorectal cancer incidence in Korea, 1999-2009.韩国 1999-2009 年结直肠癌发病率的上升趋势。
Cancer Res Treat. 2012 Dec;44(4):219-26. doi: 10.4143/crt.2012.44.4.219. Epub 2012 Dec 31.
3
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011.
1999-2018 年韩国国家癌症登记处宫颈癌的发病率和治疗结果。
J Gynecol Oncol. 2023 Mar;34(2):e39. doi: 10.3802/jgo.2023.34.e39. Epub 2023 Jan 19.
4
The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry.1999 - 2017年韩国宫颈癌、卵巢癌和子宫内膜癌的发病率及生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2021 Sep;64(5):444-453. doi: 10.5468/ogs.21116. Epub 2021 Aug 17.
5
Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.韩国上皮性卵巢癌患者接受标准治疗后的静脉血栓栓塞发生率。
Cancer Med. 2021 Mar;10(6):2045-2053. doi: 10.1002/cam4.3797. Epub 2021 Feb 26.
6
The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High-Income Countries: Canada, Korea, and Italy.年龄、时期和队列变化对加拿大、韩国和意大利三国宫颈癌死亡率的影响
Biomed Res Int. 2021 Jan 4;2021:8829122. doi: 10.1155/2021/8829122. eCollection 2021.
7
Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.子宫内膜增生患者进展为子宫内膜癌的风险因素:一项回顾性队列研究。
PLoS One. 2020 Dec 1;15(12):e0243064. doi: 10.1371/journal.pone.0243064. eCollection 2020.
8
Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution.致密粘连的上皮性卵巢癌保留生育功能手术的可行性和安全性:单中心长期结果。
J Gynecol Oncol. 2020 Nov;31(6):e85. doi: 10.3802/jgo.2020.31.e85.
9
Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.孕激素治疗子宫内膜增生患者中刮宫术与抽吸活检的诊断准确性比较:韩国妇科肿瘤学组研究。
J Gynecol Oncol. 2020 Jul;31(4):e51. doi: 10.3802/jgo.2020.31.e51. Epub 2020 Feb 7.
10
Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer.将下一代测序面板整合到卵巢癌的临床实践中。
Yonsei Med J. 2019 Oct;60(10):914-923. doi: 10.3349/ymj.2019.60.10.914.
韩国男性和女性癌症筛查率趋势:来自 2004-2011 年韩国国家癌症筛查调查(KNCSS)的结果。
Cancer Res Treat. 2012 Jun;44(2):113-20. doi: 10.4143/crt.2012.44.2.113. Epub 2012 Jun 30.
4
Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study.年轻女性宫颈癌发病率:一项基于英国区域人口的历史性和地理性对照研究。
Br J Cancer. 2012 May 22;106(11):1753-9. doi: 10.1038/bjc.2012.148. Epub 2012 Apr 24.
5
Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer.遗传性非息肉病性结直肠癌/林奇综合征在韩国子宫内膜癌患者中的表现。
Jpn J Clin Oncol. 2010 Dec;40(12):1121-7. doi: 10.1093/jjco/hyq144. Epub 2010 Oct 21.
6
Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database.韩国 1999~2001 年全国癌症发病率;首次使用全国癌症发病率数据库的结果。
Cancer Res Treat. 2005 Dec;37(6):325-31. doi: 10.4143/crt.2005.37.6.325. Epub 2005 Dec 31.
7
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.韩国卵巢癌患者的BRCA1和BRCA2种系突变
J Cancer Res Clin Oncol. 2009 Nov;135(11):1593-9. doi: 10.1007/s00432-009-0607-3. Epub 2009 Jun 5.
8
Ovarian cancer incidence and survival in Korea: 1993-2002.韩国1993 - 2002年卵巢癌的发病率与生存率
Int J Gynecol Cancer. 2007 May-Jun;17(3):595-600. doi: 10.1111/j.1525-1438.2007.00824.x. Epub 2007 Feb 9.
9
Cervical cancer incidence and survival in Korea: 1993-2002.韩国1993 - 2002年宫颈癌的发病率及生存率
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1833-8. doi: 10.1111/j.1525-1438.2006.00708.x.